Effect Evaluation of The International Child Development Programme (ICDP)
NCT ID: NCT03040895
Last Updated: 2023-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
666 participants
INTERVENTIONAL
2016-02-10
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementing Dyadic Developmental Psychotherapy (DDP) - Evaluation Research
NCT04763720
Testing the Effects of the Caregiver Interaction Profile Training on the Interactive Skills of Daycare Providers
NCT05654116
FamilieTrivsel i Almen Praksis: a Mentalisation Programme for Families With Young Children
NCT04129359
Pilot Trial of Family Partner - a Child Maltreatment Prevention Intervention
NCT04957394
The Impact of Parent Training on the Child's Health Services
NCT03704974
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to evaluate if ICDP has an effect on caregiver's positive involvement and sensitivity to childrens emotions, and on parental self-efficacy. The study will also evaluate the effect of ICDP on caregiver-child relationships, and the children's development and well-being.
The study will use a stratified cluster randomized control design, and will be implemented in regular clinical practice in Norway.
More knowledge within this field is important for practitioners as well as policy makers in planning preventive interventions for caregivers ant their children.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICDP-intervention for caregivers
Group-based ICDP-intervention for caregivers through a sequence of eight meetings. The groups are led by facilitators trained in the ICDP.
Group-based ICDP-intervention
Group-based ICDP-intervention for caregivers through a sequence of eight meetings
Treatment as usual
Participants may use other health services (GP, other interventions) as usual through the data Collection period (6 months). Afther this period, they will have the opportunity to join an ICDP-Group if they still want.
Treatment as usual
Treatment as usual through the data collection period (6 months)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group-based ICDP-intervention
Group-based ICDP-intervention for caregivers through a sequence of eight meetings
Treatment as usual
Treatment as usual through the data collection period (6 months)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants must be able to speak and write adequately Norwegian
Exclusion Criteria
* Insufficient Norwegian language skills
* ICDP imposed by resolution in the Fylkesnemnda
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Directorate for Children, Youth and Family Affairs
UNKNOWN
Norwegian Institute of Public Health
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gun-Mette B. Røsand, PhD
Role: PRINCIPAL_INVESTIGATOR
Norwegian Institute of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norwegian Institute of Public Health
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Public 360-nr. 16/13557
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.